TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive DRCCA Board Approves CCOP, Limited Recompetition Of Cooperative Group Program, New Control Efforts October 30, 1981
TCL Archive Letters From Ovarian Cancer Survivors Shed Light On Their Psychological Distress October 31, 2003
TCL Archive House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged. April 6, 2007
